GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 424 filers reported holding GLOBUS MED INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,274 | +2.6% | 45,806 | +23.1% | 0.02% | 0.0% |
| Q2 2023 | $2,216 | +10.5% | 37,220 | +5.1% | 0.02% | +15.4% |
| Q1 2023 | $2,006 | +18.6% | 35,411 | +55.5% | 0.01% | +8.3% |
| Q4 2022 | $1,691 | -99.9% | 22,768 | -7.3% | 0.01% | +9.1% |
| Q3 2022 | $1,463,000 | +61.8% | 24,556 | +52.4% | 0.01% | +83.3% |
| Q2 2022 | $904,000 | -25.1% | 16,108 | -1.5% | 0.01% | 0.0% |
| Q1 2022 | $1,207,000 | +9.4% | 16,353 | +7.1% | 0.01% | +20.0% |
| Q4 2021 | $1,103,000 | +15.6% | 15,275 | +22.7% | 0.01% | 0.0% |
| Q3 2021 | $954,000 | +23.1% | 12,454 | +24.7% | 0.01% | +25.0% |
| Q2 2021 | $775,000 | +47.9% | 9,990 | +17.6% | 0.00% | +33.3% |
| Q1 2021 | $524,000 | +15.2% | 8,497 | +21.9% | 0.00% | 0.0% |
| Q4 2020 | $455,000 | +108.7% | 6,970 | +58.4% | 0.00% | +200.0% |
| Q3 2020 | $218,000 | -55.4% | 4,401 | -49.0% | 0.00% | -66.7% |
| Q3 2018 | $489,000 | -34.1% | 8,624 | -41.3% | 0.00% | -40.0% |
| Q2 2018 | $742,000 | -7.1% | 14,704 | -8.4% | 0.01% | 0.0% |
| Q1 2018 | $799,000 | -22.0% | 16,044 | -35.7% | 0.01% | -28.6% |
| Q4 2017 | $1,025,000 | +330.7% | 24,939 | +150.1% | 0.01% | +250.0% |
| Q2 2016 | $238,000 | +14.4% | 9,972 | +13.8% | 0.00% | +100.0% |
| Q1 2016 | $208,000 | +14.3% | 8,764 | +34.3% | 0.00% | 0.0% |
| Q4 2015 | $182,000 | +1.7% | 6,526 | -24.8% | 0.00% | 0.0% |
| Q3 2015 | $179,000 | +155.7% | 8,681 | +218.9% | 0.00% | 0.0% |
| Q2 2015 | $70,000 | +100.0% | 2,722 | +95.8% | 0.00% | – |
| Q1 2015 | $35,000 | +6.1% | 1,390 | +0.1% | 0.00% | – |
| Q4 2014 | $33,000 | +10.0% | 1,388 | -10.3% | 0.00% | – |
| Q3 2014 | $30,000 | -18.9% | 1,548 | -0.7% | 0.00% | – |
| Q2 2014 | $37,000 | -24.5% | 1,559 | -15.5% | 0.00% | – |
| Q1 2014 | $49,000 | +32.4% | 1,846 | +0.8% | 0.00% | – |
| Q4 2013 | $37,000 | -65.4% | 1,831 | -70.2% | 0.00% | -100.0% |
| Q3 2013 | $107,000 | +55.1% | 6,153 | +51.3% | 0.00% | 0.0% |
| Q2 2013 | $69,000 | – | 4,066 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |